aod9604 dosing frequency subcutaneous injection AOD-9604 Dosage Guide: Complete Protocol for Safe Administration Safety and Tolerability of the

Therapy continues as long as positive changes occur and is adjusted or discontinued if plateaus develop or goals are achieved

RESEARCH USE ONLY - FDA DISCLAIMER: All products are intended for research use only as defined by the FDA

Baseline scan before starting, follow-up at 6-8 weeks, and final assessment at protocol completion enable accurate fat loss quantification

Personalized Care Every protocol is designed around your specific health goals, injury history, and recovery timeline

however, one injection in the morning 30 minutes before food will allow for the body to fully metabolize the AOD 9604

Peptides are no longer just a fringe tool for elite athletes and anti-aging clinics and 5-Amino-1MQ is one of the most promising new compounds to emerge